Post‐treatment urinary sarcosine as a predictor of recurrent relapses in patients with prostate cancer

To date, there has been no evidence regarding the association between urinary sarcosine content and prostate cancer survival. Our main objective was to investigate whether levels of post‐treatment urinary sarcosine are associated with relapse. The inclusion criteria were (in accordance with EAU 2017...

Descripción completa

Detalles Bibliográficos
Autores principales: Gumulec, Jaromir, Raudenska, Martina, Pacik, Dalibor, Plevova, Mariana, Sorokac‐Kubolkova, Alena, Lackova, Zuzana, Cernei, Natalia, Strmiska, Vladislav, Zitka, Ondrej, Heger, Zbynek, Adam, Vojtech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246947/
https://www.ncbi.nlm.nih.gov/pubmed/30209891
http://dx.doi.org/10.1002/cam4.1767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6246947/
https://www.ncbi.nlm.nih.gov/pubmed/30209891
http://dx.doi.org/10.1002/cam4.1767

Ejemplares similares